An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis

Clinical and Experimental Metastasis

Volumn 24, Issue 5, 2007, Pages 379-387

  Van Nimwegen, Maroesja J ^a   Verkoeijen, Saertje ^a   Kuppen, Peter J K ^b   Velthuis, Jurjen H L ^a,b   Van De Water, Bob ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fischer 344 rats; Metastasis; MTLn3 cells; NK cells

Indexed keywords

GRANZYME B; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER MODEL; CELL ISOLATION; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FISCHER 344 RAT; IMMUNE DEFICIENCY; IMMUNOASSAY; IN VIVO STUDY; LUNG METASTASIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN FUNCTION; RAT; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, NATURAL; INTERLEUKIN-2; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; NEOPLASM TRANSPLANTATION; PORE FORMING CYTOTOXIC PROTEINS; RATS; RATS, INBRED F344; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 34547169485     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9075-9     Document Type: Article

References (24)

1. Khanna C, Hunter K (2005) Modeling metastasis in vivo. Carcinogenesis 26:513-523
2. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359-93
3. Neri A, Welch D, Kawaguchi T et al (1982) Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68:507-517
4. Welch DR, Neri A, Nicolson GL (1983) Comparison of 'spontaneous' and ''experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 3:65-80
5. Bouzahzah B, Albanese C, Ahmed F et al (2001) Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7:816-830
6. Melamed R, Rosenne E, Shakhar K et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114-126
7. Ben Eliyahu S, Page GG, Yirmiya R et al (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2:457-460
8. Ben Eliyahu S, Page GG, Yirmiya R et al (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80:880-888
9. Barlozzari T, Leonhardt J, Wiltrout RH et al (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134:2783-2789
10. Huigsloot M, Tijdens IB, Mulder GJ et al (2002) Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 277:35869-35879
11. Huigsloot M, Tijdens RB, van de Water B (2003) Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2. Mol Pharmacol 64:965-973
12. van Nimwegen MJ, Huigsloot M, Camier A et al (2006) Focal adhesion kinase (FAK) and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol Pharmacol 70:
13. van Nimwegen MJ, Verkoeijen S, van Buren L et al (2005) Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 65:4698-4706
14. Velthuis JH, de Bont HJ, Medema JP et al (2003) Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells. Immunobiology 207:115-127
15. Fukumoto T, McMaster WR, Williams AF (1982) Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol 12:237-243
16. Huigsloot M, Tijdens IB, Mulder GJ et al (2001) Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells. Biochem Pharmacol 62:1087-1097
17. van den Brink MR, Hunt LE, Hiserodt JC (1990) In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 171:197-210
18. Velthuis JH, Stitzinger M, Aalbers RI et al (2003) Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis. Clin Exp Metastasis 20:713-721
19. Nausch N, Florin L, Hartenstein B et al (2006) Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. J Immunol 176:7-11
20. Savithri B, Khar A (2006) A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D. Eur J Immunol 36:107-117
21. Smyth MJ, Swann J, Cretney E et al (2005) NKG2D function protects the host from tumor initiation. J Exp Med 202:583-588
22. Le Maux CB, Moretta A, Vergnon I et al (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 175:5790-5798
23. Velthuis JH, Rouschop KM, de Bont HJ et al (2002) Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 277:24,631-24,637
24. Welch DR, Aeed PA, Earhart RH et al (1994) Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones. Anticancer Res 14:1743-1751